Venus Remedies informs about disclosure

05 Dec 2023 Evaluate

Venus Remedies has informed that the company achieves a significant milestone with the recent approval of marketing authorizations (MAs) for Enoxaparin 40 mg/0.4 ml and 60 mg/0.6 ml in Azerbaijan, marking the first entry of these products into the country. Enoxaparin Sodium Injection, a low molecular weight heparin, effectively prevents blood clot enlargement and formation, addressing various medical conditions.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×